[go: up one dir, main page]

PE20220805A1 - Composiciones de recubrimientos en pelicula para tabletas con brillantez incrementada, procedimiento de preparacion y aplicacion - Google Patents

Composiciones de recubrimientos en pelicula para tabletas con brillantez incrementada, procedimiento de preparacion y aplicacion

Info

Publication number
PE20220805A1
PE20220805A1 PE2021002054A PE2021002054A PE20220805A1 PE 20220805 A1 PE20220805 A1 PE 20220805A1 PE 2021002054 A PE2021002054 A PE 2021002054A PE 2021002054 A PE2021002054 A PE 2021002054A PE 20220805 A1 PE20220805 A1 PE 20220805A1
Authority
PE
Peru
Prior art keywords
tablets
compositions
preparation
film coatings
application procedure
Prior art date
Application number
PE2021002054A
Other languages
English (en)
Inventor
Rodriguez Francisco Escorcia
Mondragon Maria De Lourdes Garcia
Navarrete Ana Karen Flores
Rodriguez Jose Luis Espitia
Original Assignee
Dva Farma Mexicana S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dva Farma Mexicana S A De C V filed Critical Dva Farma Mexicana S A De C V
Publication of PE20220805A1 publication Critical patent/PE20220805A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

Referido a una composicion de recubrimiento para formas farmaceuticas solidas, seleccionadas del grupo que consiste en tabletas, suplementos, pildoras, entre otras; caracterizada porque comprende: a) Un derivado de isomaltulosa; b) Polimeros adherentes; y c) Aditivos individuales o combinados, donde la composicion de recubrimiento es un recubrimiento de pelicula. Estos recubrimientos de pelicula se logra obtener producto final recubierto con brillantez superior a la alcanzable con composiciones tipicas. Tambien se refiere a formulaciones que comprende dicha composicion, y sus procesos de preparacion.
PE2021002054A 2019-07-15 2020-07-13 Composiciones de recubrimientos en pelicula para tabletas con brillantez incrementada, procedimiento de preparacion y aplicacion PE20220805A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MX2019008440A MX2019008440A (es) 2019-07-15 2019-07-15 Composiciones de recubrimientos en pelicula para tabletas con brillantez incrementada, procedimiento de preparacion y aplicacion.
PCT/MX2020/050017 WO2021010814A2 (es) 2019-07-15 2020-07-13 Composiciones de recubrimientos en película para tabletas con brillantez incrementada, procedimiento de preparación y aplicación

Publications (1)

Publication Number Publication Date
PE20220805A1 true PE20220805A1 (es) 2022-05-20

Family

ID=74211167

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2021002054A PE20220805A1 (es) 2019-07-15 2020-07-13 Composiciones de recubrimientos en pelicula para tabletas con brillantez incrementada, procedimiento de preparacion y aplicacion

Country Status (8)

Country Link
US (1) US20220233450A1 (es)
EP (1) EP4000605A4 (es)
AR (1) AR119406A1 (es)
BR (1) BR112021015768A2 (es)
CO (1) CO2022001370A2 (es)
MX (1) MX2019008440A (es)
PE (1) PE20220805A1 (es)
WO (1) WO2021010814A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4324465A1 (en) * 2022-08-15 2024-02-21 Gedea Biotech AB Compounds for use in the treatment of a microbial infection in the urogenital system

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2810189A (en) * 1987-10-30 1989-05-23 Stolle Research & Development Corporation Low residual solvent microspheres and microencapsulation process
US5665406A (en) * 1992-03-23 1997-09-09 Wm. Wrigley Jr. Company Polyol coated chewing gum having improved shelf life and method of making
ES2226107T3 (es) * 1997-01-06 2005-03-16 Bpsi Holdings, Inc. Recubrimiento de pelicula, y compsiciones de recubrimientos de pelicula, a base de dextrina.
DE10207427A1 (de) * 2002-02-21 2003-09-04 Basf Ag Schnelllöslicher Filmüberzug basierend auf Polyvinylalkohol-Polyether-Pfropfcopolymeren in Kombination mit Hydroxy-, Amid-, oder Esterfunktionen enthaltenden Komponenten
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
PE20060245A1 (es) * 2004-06-07 2006-05-03 Wyeth Corp Recubrimientos de azucar y metodos para la fabricacion de los mismos
FR2921835B1 (fr) * 2007-10-05 2012-05-04 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Composition d'enrobage comprenant du polydextrose, procede pour sa preparation et utilisation pour enrober les formes solides ingerables
EP2227225B1 (en) 2008-01-10 2018-11-14 Evonik Röhm GmbH Coated pharmaceutical or nutraceutical preparation with enhanced pulsed active substance release
US20090214699A1 (en) * 2008-02-25 2009-08-27 Bernd Hasslinger Coated comestibles and processes for their preparation
WO2010052727A1 (en) 2008-11-04 2010-05-14 Ideal Cures Private Limited High performance film coating compositions
ES2561181T3 (es) 2009-02-05 2016-02-24 Takeda Pharmaceutical Company Limited Compuestos de piridazinona
EP2429504A4 (en) * 2009-05-12 2013-05-01 Bpsi Holdings Llc FILM COATINGS WITH DECEPTORS IN FINE PARTICLE SIZES AND SUBSTRATES COATED THEREFOR
WO2011143347A2 (en) * 2010-05-11 2011-11-17 Sensient Colors Llc Film coating composition and methods of making and using the same
US20130084338A1 (en) * 2011-09-30 2013-04-04 Basf Se Method For Producing Solid Pigment-Containing Film Coating Compositions In The Form Of Granules Based On Enteric Film Formers For Pharmaceutical Dosage Forms
BE1020860A3 (nl) 2012-08-09 2014-06-03 Ecover Co Ordination Ct Nv Tablet coating.
WO2015131007A2 (en) * 2014-02-28 2015-09-03 Intercontinental Great Brands Llc Coating for edible cores; system and process of coating; and coated products prepared therefrom

Also Published As

Publication number Publication date
EP4000605A2 (en) 2022-05-25
BR112021015768A2 (pt) 2022-02-08
MX2019008440A (es) 2021-01-18
EP4000605A4 (en) 2022-08-24
WO2021010814A2 (es) 2021-01-21
CO2022001370A2 (es) 2022-03-18
US20220233450A1 (en) 2022-07-28
WO2021010814A3 (es) 2021-04-15
AR119406A1 (es) 2021-12-15

Similar Documents

Publication Publication Date Title
EP4512399A3 (en) Solid state forms of tafamidis and salts thereof
WO2020102766A3 (en) Methods for generating circular nucleic acid molecules
UY37952A (es) Formulaciones de un inhibidor de la quinasa trk macrocíclica
PL3927312T3 (pl) Minimalizacja aglomeracji, napowietrzania i konserwacji powłoki kompozycji farmaceutycznych zawierających Ibuprofen
ATE457719T2 (de) Pharmazeutische zusammensetzungen mit kontrollierter freisetzung für säurelabile arzneimittel
PE20220805A1 (es) Composiciones de recubrimientos en pelicula para tabletas con brillantez incrementada, procedimiento de preparacion y aplicacion
ZA201905664B (en) Novel dosage form
WO2017139331A8 (en) Pharmaceutical bead formulations comprising dimethyl fumarate
ECSP21062210A (es) Derivados de aminoácidos para el tratamiento de enfermedades inflamatorias
WO2025057086A3 (en) Pharmaceutical compositions comprising nipocalimab
MX393915B (es) Nuevas formulaciones orales de belinostat.
EA202190328A1 (ru) Фармацевтическая композиция, содержащая тикагрелор
EP3409301A3 (en) Resorbing biodegradable medical and cosmetic composition
WO2022040111A3 (en) Solid state forms of erdafitinib salts and processes for preparation of erdafitinib
CO2021012209A2 (es) Composición para cuidado oral
MX2022000069A (es) Formas sólidas de (s)-2-((2s,3r)-1-amino-3-hidroxi-1-oxobutan-2-il )-1-oxo 2,5-diazaspiro[3.4]octano-5-carboxilato de terc-butilo y métodos para prepararlas.
WO2023173111A3 (en) Intra-dosage form coatings and applications thereof
WO2019079095A3 (en) Composition and method of preparation of risperidone extended release preparation
WO2020086650A3 (en) Novel compounds
WO2020033874A8 (en) Comestible compositions for promoting atp synthesis
MX2020004056A (es) Composición de recubrimiento de silicona modificada.
AR100820A1 (es) Formulaciones de comprimido bi-capa de ciclofosfamida y capecitabina y administración metronómica altamente fraccionada de las mismas
EA201691518A1 (ru) Композиции, содержащие продукты пчеловодства
PH12022551041A1 (en) Crizanlizumab containing antibody formulation
DOP2018000291A (es) LACTONAS SESQUITERPÉNICAS DE Koanophyllon gibbossum, Y SU USO PARA EL TRATAMIENTO DE DISTINTOS TIPOS DE CÁNCER.